Remove 2016 Remove Healthcare Remove Side effects
article thumbnail

Are new weight loss drugs an answer or problem?

World of DTC Marketing

Worldwide obesity rates have tripled since 1975, with 650 million adults obese in 2016, according to the World Health Organization. It has to persuade patients to sign up for some heinous side effects. In 2019, the OECD declared that developed countries’ plans to tackle the problem largely failed.

article thumbnail

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Medgadget

These treatments at times come with a long list of side effects, leaving many patients in search of an effective long-term solution. For some patients with PTSD, psychotherapy may not be an effective option, they may find talking about their traumatic experience stress inducing, untherapeutic or ineffective.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?

Clarivate

A ‘magic bullet’ medicine that can cure a disease quickly and completely, [1] without deleterious side effects. [2] 6] As many pathogenetic targets have multiple physiological functions, highly specific ‘magic bullets’ may impact multiple cellular pathways simultaneously, causing unintended side effects.7 Chin J Cancer.

article thumbnail

Regulators and HTAs tune in to patient preference data

Clarivate

Obtaining the preferences of patients and their caregivers is not a new concept in healthcare. Increasingly, however, industry guidance documents utilize the term ‘patient preference’ in relation to new drug development and benefit-risk assessment.

article thumbnail

How Pharmacogenomics may finally realise its promise

pharmaphorum

In 2016, the estimated annual cost of drug-related morbidity and mortality resulting from non-optimised medication therapy was $528.4 There have been great strides made in genomics to refine tools that determine the safest, most effective course of treatments for patients across a number of disease states.

article thumbnail

Developing the EU’s first intestinal microbiota-based biologic

European Pharmaceutical Review

The specific representation of these events differed between the treatments, highlighting potential differences in side effect profiles that should be explored in further studies. 2016; 46: 479–93. Adverse events were relatively low in both groups (2.22 percent for MBK-01 and 4.26 percent for fidaxomicin). Intern Med J.

Safety 111
article thumbnail

Precision Medicine Needs an Overhaul

PM360

Unlike the “un”targeted approaches that are often associated on the trial-and-error method, an expanded definition of precision medicine, with a smarter and more integrated tool set, will enable healthcare professionals (HCPs) to try the optimal therapeutic approach… the first time.